Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

@article{Cardamone2013AntidepressantTI,
  title={Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?},
  author={Lisa Cardamone and Michael R. Salzberg and Terence J. O'Brien and Nigel C. Jones},
  journal={British journal of pharmacology},
  year={2013},
  volume={168 7},
  pages={1531-54}
}
There is a high incidence of psychiatric comorbidity in people with epilepsy (PWE), particularly depression. The manifold adverse consequences of comorbid depression have been more clearly mapped in recent years. Accordingly, considerable efforts have been made to improve detection and diagnosis, with the result that many PWE are treated with antidepressant drugs, medications with the potential to influence both epilepsy and depression. Exposure to older generations of antidepressants (notably… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 6 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

Agmatine for combined treatment of epilepsy, depression and cognitive impairment in chronic epileptic animals.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie • 2017
View 10 Excerpts
Highly Influenced

Successful management of bupropion poisoning : Possible benefit of acidosis treatment

İsmail Altıntop, Mehmet Tatlı
2017
View 4 Excerpts
Highly Influenced

Antidepressant drug paroxetine blocks the open pore of Kv3.1 potassium channel

The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology • 2018
View 3 Excerpts

Similar Papers

Loading similar papers…